Français 784

Contient : 1° « Le Roumanz de Thebes » ; 2° « Le Roumans de Heneas »

Na 50 Nachlass Arthur Schopenhauer - 'Schopenhauer-Archiv', 784 - Bestätigung über den Erhalt des Pachtvertrages

u.a. Angaben zum Immobilienmarkt in Danzig; Reise nach Italien; Pachtverkauf;

Mus Hs 784 - Conzertino für das Second-Horn mit Begleitung: 1nes Fagott's, 2er Clarinetten in A, 1ner Floete, 2er Violinen, Viola, Violoncello und Basso

Karl Oestreich

Kohler E. y M. Klinkowski. Viruskrankheiten, publicado como el volumen 2, parte 1º del Handbuch Der Pflanzenkrankheiten de P. Sorauer, 784 pág. 326 fgs. Edit. por Paul Parey, Berlín. 1954

Fil: Pontis, Rafael E..

Noções gerais acerca do processo administrativo e da Lei nº 9.784/99

Inclui notas explicativas e bibliografia

Organizational, direct support, and general support maintenance repair parts and special tools lists (including depot maintenance repair parts and special tools) for antenna loop AT-784/PRC (NSN 5820-00-086-7651).

Includes index.

Operator, organizational, DS, GS, and depot maintenance manual including repair parts, special tools lists : antenna, loop AT-784/PRC (NSN 5820-00-086-7651).

"February 1967."

The regulation of insurance intermediaries in the Australian financial services market

The insurance industry discharges a critical role in the Australian economy and is a significant part of the Australian financial services market. The industry relies upon intermediaries, the principal types being brokers and agents, to promote, arrange and distribute their products and services in the market. The pivotal role that they play in this context and sensitivities associated with the consumer oriented products, such as house and contents insurance, has ensured close regulatory attention. Of particular importance was the passage of the Insurance (Agents and Brokers) Act 1984 (Cth), a comprehensive attempt to address the responsibilities of intermediaries as well as particular problem areas associated with the handling of money. However, with the introduction of financial services and market reform early in the new millennium this insurance intermediary specific regulatory approach was abandoned in favour of a market-wide strategy; that is, market reform was based upon across-the-board licensing, disclosure, conduct and fairness standards, and all financial products and services are now regulated at a generic level under Ch 7 of the Corporations Act 2001 (Cth). This article briefly explores the categories of insurance intermediaries and the relevant distinctions between them but focuses mainly upon the regulatory context in which they operate. This context transcends a strictly legal framework as the regulatory body, the Australian Securities and Investments Commission (ASIC), has sought to inform and guide the market through Policy Statements and Regulatory Guides. The usefulness of these guides as an adjunct to the legislation in explaining the scope and operation of regulatory framework is examined. In addition, the article looks at the self-regulatory and dispute resolution practices in this area and their impact. In conclusion an assessment of this across-the-board regulatory regime is advanced.

Low frequency of CHEK2 1100delC allele in Australian multiple-case breast cancer families : functional analysis in heterozygous individuals

A protein-truncating variant of CHEK2, 1100delC, is associated with a moderate increase in breast cancer risk. We have determined the prevalence of this allele in index cases from 300 Australian multiple-case breast cancer families, 95% of which had been found to be negative for mutations in BRCA1 and BRCA2. Only two (0.6%) index cases heterozygous for the CHEK2 mutation were identified. All available relatives in these two families were genotyped, but there was no evidence of co-segregation between the CHEK2 variant and breast cancer. Lymphoblastoid cell lines established from a heterozygous carrier contained approximately 20% of the CHEK2 1100delC mRNA relative to wild-type CHEK2 transcript. However, no truncated CHK2 protein was detectable. Analyses of expression and phosphorylation of wild-type CHK2 suggest that the variant is likely to act by haploinsufficiency. Analysis of CDC25A degradation, a downstream target of CHK2, suggests that some compensation occurs to allow normal degradation of CDC25A. Such compensation of the 1100delC defect in CHEK2 might explain the rather low breast cancer risk associated with the CHEK2 variant, compared to that associated with truncating mutations in BRCA1 or BRCA2.